Key Takeaways
- Nvidia (NVDA) shares fell 5% as the company pursues over $750 billion in AI infrastructure deals, sparking intense investor fears regarding "circular financing" and systemic risk.
- Johnson & Johnson (JNJ) announced a proposed $5.5 billion settlement to resolve approximately 76,000 ovarian talc claims, with the first payment of $3 billion due in 2027.
- UK Shop Price Index rose just 0.9% year-over-year in July, coming in below estimates of 1.1% as food inflation fell for the sixth consecutive month.
- BlackRock (BLK) successfully priced a $12.3 billion bond deal for a Meta Platforms (META) data center; despite initial weak demand, the bonds rallied in the gray market due to attractive yields.
- Ether (ETH) experienced a sharp decline, falling 3.03% to $1,886.35 during late-day trading.
Nvidia’s $750 Billion Ambition Ignites "Circular Financing" Alarm
Nvidia (NVDA) is currently navigating a wave of skepticism as it advances a massive $750 billion deal pipeline aimed at cementing its dominance in the AI sector. This includes a $500+ billion partnership with SK Group and a proposed $250 billion financing backstop for OpenAI. While Nvidia defends the strategy as essential for building global AI infrastructure, critics warn of "circular financing," where the chipmaker essentially finances its own future demand.
The market reaction has been swift and cautious. Nvidia shares tumbled 5% following the news, and the cost of insuring the company's debt against default hit a record high. Investors are increasingly concerned that these mega-deals may be artificially inflating AI valuations by creating a closed loop of capital between the supplier and its primary customers.
Johnson & Johnson Moves to Resolve Decades-Long Talc Litigation
Johnson & Johnson (JNJ) has committed $5.5 billion to settle roughly 76,000 lawsuits alleging that its talc-based products caused ovarian cancer. Under the proposed resolution, the healthcare giant would make its first payment of up to $3 billion in 2027, with no additional payments scheduled before 2028. The company characterized the deal as an "efficient conclusion" to the litigation.
Despite the multi-billion dollar commitment, J&J continues to maintain that its talc is safe and does not cause cancer. The settlement is designed to provide certainty for shareholders and put an end to a legal battle that has weighed on the company's valuation for years. Sources indicate the resolution is contingent on high levels of claimant participation to ensure a final exit from the litigation.
UK Inflation Eases as Shop Prices Underperform Estimates
The British Retail Consortium (BRC) reported that the UK Shop Price Index rose by 0.9% year-over-year in July, a significant deceleration from the 1.2% recorded in June. This figure came in below the consensus estimate of 1.1%, providing further evidence that inflationary pressures in the UK are cooling faster than anticipated.
Food inflation has now fallen for six consecutive months, a trend that offers much-needed relief to British households. Retailers have attributed the slowdown to intense competition and a wave of summer promotions. The lower-than-expected data may increase pressure on the Bank of England to consider more aggressive interest rate cuts in the coming months.
BlackRock and Palantir Navigate Shifting AI Sentiment
In the credit markets, BlackRock (BLK) managed to stabilize a $12.3 billion bond offering for a massive Meta Platforms (META) data center project. Although the deal initially saw soft demand, the bonds tightened in the gray market as investors were drawn to higher-than-usual yields. This recovery suggests that while investors are becoming more selective, there is still significant liquidity available for well-structured AI infrastructure debt.
Meanwhile, Palantir (PLTR) CEO Alex Karp has issued a stern warning to U.S. policymakers, urging the Trump administration not to follow Europe’s path of strict AI regulation. Karp specifically advocated against banning open-weight models, arguing that such restrictions would stifle American innovation and hand a competitive advantage to foreign adversaries. He described Europe's regulatory environment as a "cautionary tale" that has effectively regulated its tech sector out of global relevance.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.